US Earnings Financial Results SEC Filings — June 08, 2026

08-06-2026

Enviri Corporation reported a net loss attributable to common stockholders of $10.7M for Q1 2026, widening from a $9.0M loss in Q1 2025, with operating income collapsing 97% to $0.8M from $29.3M. Total revenues were essentially flat at $549.8M (+0.3% YoY), as service revenue growth of 1.6% was offset by a 7.9% decline in product revenues. The company recorded a large deferred income tax benefit of $30.2M that partially offset the operating loss, but cash flow from operations improved to $21.5M from $6.6M.

• · Total assets decreased slightly to $2.704B from $2.709B at year-end 2025.
• · Total equity fell to $274.9M from $295.6M, driven by a $10.7M net loss and $6.4M in foreign currency translation losses.
• · Long-term debt increased to $1.557B from $1.530B, with net borrowings of $31M under the Revolving Credit Facility.
• · Capital expenditures rose 56% to $33.7M from $21.6M in Q1 2025.
• · Basic and diluted loss per share worsened to $(0.13) from $(0.11) in the prior year quarter.
• · The company's effective tax rate was significantly impacted by a $30.2M deferred tax benefit, compared to a $2.8M deferred tax expense in Q1 2025.
• · Restricted cash increased to $15.8M from $2.0M a year ago.
• · Goodwill decreased slightly to $753.9M from $758.7M.

08-06-2026

ChargePoint Holdings, Inc. reported a net loss of $43.2M for Q1 FY26 (three months ended April 30, 2026), improving from a net loss of $57.1M in the same period last year. Total revenue grew 4.3% YoY to $101.8M, driven by increases in Networked Charging Systems (+2.4%) and Subscriptions (+7.2%). However, the company's cash and cash equivalents declined sharply from $141.6M to $95.8M, and total stockholders' equity turned negative to ($9.1M) from $21.3M at the start of the quarter.

• · Gross profit improved to $29.6M from $28.0M YoY, with gross margin rising to 29.1% from 28.7%.
• · Operating expenses decreased 6.2% YoY to $76.8M, driven by lower sales and marketing ($23.6M vs $26.2M) and G&A ($17.6M vs $22.1M), partially offset by higher R&D ($35.6M vs $33.5M).
• · Interest expense dropped sharply to $0.3M from $6.4M YoY due to lower debt and paid-in-kind interest.
• · Accounts receivable decreased to $80.6M from $86.1M, while inventories fell to $203.6M from $214.9M.
• · Total debt (current + noncurrent) was $239.7M as of April 30, 2026, down from $260.9M at January 31, 2026.
• · Stock-based compensation was $10.6M in Q1 FY26, down from $17.9M in Q1 FY25.
• · The company issued 1.2M shares of common stock for contractual Interest Shares, valued at $6.6M.
• · Net loss per share improved to ($1.75) from ($2.49) YoY.

08-06-2026

Noble Romans Inc. reported a strong turnaround in FY 2025 (year ended December 31, 2025), swinging from a net loss of $3,174 in FY 2024 to net income of $1,173,224. Total revenue grew 8.7% to $16.5M, driven by franchising revenue up 12.1% and non-traditional restaurant revenue up 26.4%. However, cash decreased 24.9% to $533,670 and the company's non-traditional restaurant segment remained unprofitable, with a negative margin contribution of $57,147.

• · Non-traditional restaurant segment had a negative margin contribution of $57,147 in FY 2025, slightly improved from -$47,072 in FY 2024.
• · The company's cash balance declined to $533,670 as of December 31, 2025 from $710,227 a year earlier.
• · Current portion of Corbel loan payable surged 413% to $5,470,824, and convertible subordinated notes increased from $0 to $575,000, contributing to a 147% rise in total current liabilities to $8,198,440.
• · Depreciation and amortization expense decreased 21.4% to $392,948.
• · General and administrative expenses declined 12.7% to $2,336,422.
• · Interest expense decreased 18.4% to $1,336,773.
• · Cost of new warrants issued in FY 2025 was $469,542, which was $0 in FY 2024.
• · Net change in warrant-related earnings effect was a loss of $521,978 in FY 2025 versus a small gain of $1,828 in FY 2024.
• · Diluted income per share was $0.04 in FY 2025, up from $0.00 in FY 2024.
• · Company-owned restaurant margin improved from 9.2% to 10.1%.
• · Franchising margin improved from 69.3% to 72.5%.

08-06-2026

Aeries Technology, Inc. filed its 10-K annual report for the fiscal year ended March 31, 2026, reporting a net income of $3.47M, a sharp turnaround from a net loss of $21.60M in the prior year. While the company achieved positive net income and expanded gross margins to 25%, total revenue remained essentially flat at $70.01M (down 0.3% YoY), with North America revenue declining 4.0% to $62.87M. Adjusted EBITDA improved to $8.31M (11.9% margin) versus a negative $4.65M (6.6% margin) in FY2025, but the improvement was driven largely by a 72% reduction in SG&A expenses from $45.49M to $12.78M, which included significant decreases in stock-based compensation and transaction costs.

• · Revenue from Asia Pacific and Other segment grew 51.5% to $7.14M, partially offsetting the 4.0% decline in North America ($62.87M from $65.49M).
• · Cost of Revenue decreased slightly by 1.4% to $52.72M from $53.48M.
• · SG&A expenses were slashed by 71.9% to $12.78M, primarily due to reductions in stock-based compensation ($12.75M to not separately disclosed) and Business Combination/M&A costs ($7.0M to $1.0M).
• · Depreciation and amortization fell to $0.84M from $1.38M.
• · The company swung from an operating loss of $28.77M to an operating income of $4.52M.
• · Net income attributable to shareholders was $2.55M versus a loss of $19.71M in the prior year.
• · Adjusted EBITDA turned positive at $8.31M (11.9% margin) from negative $4.65M (6.6% margin).
• · The company disclosed that clients have the right to terminate auto-renewal contracts, creating revenue risk.
• · There is risk of adverse effects from uncollected receivables, particularly in the Middle East and Asia Pacific region.
• · The company flagged dilution risk from registered shares on Form S-1 (333-276173) and additional equity issuances.

08-06-2026

Seaport Therapeutics, Inc. reported a net loss of $25.4M for Q1 2026, nearly double the $13.1M loss in Q1 2025, driven by a 103% surge in R&D spending to $21.4M. Total assets declined 8.6% to $227.7M from $249.0M at year-end 2025, while the accumulated deficit widened to $139.5M. However, cash and cash equivalents increased to $52.9M from $46.0M, and operating cash burn remained nearly flat at $20.2M.

• · Net loss per share (basic and diluted) worsened to $(10.34) in Q1 2026 from $(5.65) in Q1 2025.
• · Short-term investments decreased to $129.7M from $169.9M at year-end 2025, while long-term investments increased to $30.0M from $17.7M.
• · Total liabilities rose to $18.0M from $16.2M, primarily due to higher accounts payable ($4.8M vs $2.0M).
• · Stockholders' deficit deepened to $(115.6M) from $(92.5M) at December 31, 2025.
• · The company received $75.0M in proceeds from maturities of investments during Q1 2026, compared to none in Q1 2025.
• · Deferred offering costs of $0.8M were paid in Q1 2026, with an additional $0.5M included in accounts payable and accrued expenses.
• · Prepaid research and development dropped sharply to $1.2M from $3.0M at year-end 2025.
• · Australia research and development tax credit receivable increased to $1.9M from $1.3M.
• · Total financial assets (cash equivalents and investments) were $212.0M as of March 31, 2026, down from $233.3M at December 31, 2025.
• · All investments are in U.S. treasuries (Level 2) and money market funds (Level 1).

08-06-2026

Campbell's reported Q3 FY2026 net sales of $2,366M, down 4.4% YoY from $2,475M, while net earnings attributable to the company rose to $124M from $66M, driven by lower other expenses. For the nine months, net sales decreased 4.1% to $7,607M from $7,932M, but net earnings increased slightly to $463M from $457M. Operating cash flow declined to $839M from $872M, and total debt increased to $7,010M from $6,857M.

• · Q3 gross margin improved to 27.5% from 29.4% in prior year (cost of products sold as % of net sales: 72.5% vs 70.6%).
• · Q3 other expenses/income decreased significantly to $8M from $160M, primarily due to impairment charges in prior year.
• · Nine months restructuring charges were $15M vs $17M prior year.
• · Total debt increased to $7,010M from $6,857M at fiscal year-end.
• · Cash and cash equivalents increased to $402M from $132M at fiscal year-end.
• · Dividends paid in nine months were $354M vs $343M prior year.
• · Treasury stock purchases in nine months were $26M vs $60M prior year.

08-06-2026

GRAHAM CORP reported net sales of $245,293,000 for fiscal year 2026, a 17% increase from $209,896,000 in fiscal 2025, driven primarily by a 21% growth in the Defense market. However, net income rose only 2% YoY to $12,500,000, and the Space market saw a slight decline of 1%. The company provided fiscal 2027 guidance with net sales expected between $285,000,000 and $295,000,000.

• · Total assets increased 23% YoY to $323,616,000 from $264,110,000.
• · Cash and cash equivalents dropped to $6,580,000 from $21,577,000, a 69.5% decrease.
• · Working capital was nearly depleted, falling to $184,000 from $5,222,000.
• · Fiscal 2027 guidance includes net sales $285M-$295M, gross profit margin 24.5%-25.5%, and Adjusted EBITDA $35M-$40M.
• · Defense market net sales grew 21% YoY, while Space market declined slightly (-1%) and international sales fell 11%.
• · SG&A expenses rose 11% YoY to $43,354,000, though as a percent of sales they improved to 17.7% from 18.5%.

08-06-2026

FuelCell Energy reported a net loss attributable to common stockholders of $78.7M for Q2 FY2026 (three months ended April 30, 2026), widening from a $38.8M loss in the prior-year quarter, driven by a $42.6M impairment expense. Total revenues declined 4.8% YoY to $35.6M, with significant drops in Service (-48.7%) and Generation (-28.4%) segments, partially offset by Product revenue growth of 38.3%. The company raised $155.3M net from common stock sales during the six-month period, boosting cash and equivalents to $373.2M from $278.1M at fiscal year-end.

• · Impairment expense of $42.6M was recorded in Q2 FY2026, contributing significantly to the widened loss.
• · Total assets increased to $1.003B from $932.1M at fiscal year-end, driven by higher cash and other assets.
• · Total liabilities rose to $215.0M from $201.0M, with long-term debt and other liabilities increasing to $129.6M.
• · Accumulated deficit deepened to $(1.930B) from $(1.829B) at October 31, 2025.
• · Noncontrolling interests remained relatively stable at $9.1M.
• · The company's VIE assets totaled $293.9M as of April 30, 2026, down from $325.7M at October 31, 2025.
• · Administrative and selling expenses decreased 10.7% YoY in Q2 to $14.7M, and R&D expenses fell 22.1% to $7.7M.
• · Interest income increased to $2.5M in Q2 from $1.8M a year ago, while interest expense rose to $2.9M from $2.5M.

08-06-2026

Motorcar Parts of America Inc (MPAA) filed its 10-K for the fiscal year ended March 31, 2026, reporting net sales of $789,806,000, up 4.3% from $757,354,000 in FY2025. Gross profit increased to $159,901,000 from $153,828,000, though gross profit percentage slightly declined to 20.2% from 20.3%. Cash flow from operations dropped sharply to $19,158,000 from $45,477,000 in the prior year, a decline of 57.9%, while net cash increased to $5,221,000 from a net decrease of $4,545,000 in FY2025.

• · Finished goods turnover improved to 3.9x in FY2026 from 3.8x in FY2025 and 3.7x in FY2024.
• · Cash used in investing activities was $3,590,000 in FY2026, compared to $4,469,000 in FY2025.
• · Cash used in financing activities was $10,980,000 in FY2026, down from $44,655,000 in FY2025.
• · Effect of exchange rates on cash was positive $633,000 in FY2026 versus negative $898,000 in FY2025.
• · Marketing allowances recorded as contract liabilities at March 31, 2026 were $19,616,000.
• · Weighted average days for receivables discounted increased slightly to 346 days in FY2026 from 343 days in FY2025.

08-06-2026

Mission Produce reported a net loss of $7.2M for Q2 FY2026, compared to net income of $3.1M in the prior-year quarter, driven by a 23.5% decline in net sales to $290.9M and $13.4M in transaction advisory costs for the six-month period. While gross profit fell to $20.5M from $28.4M, the company increased long-term debt by $100M and saw equity method income rise to $1.3M. However, operating cash flow worsened to a use of $21.0M in H1 FY2026 from $13.0M in H1 FY2025, and inventory surged 44.7% to $116.6M.

• · Transaction advisory costs totaled $13.4M for the six months ended April 30, 2026, compared to $0.2M in the prior-year period.
• · Net cash used in operating activities was $21.0M in H1 FY2026, worsening from $13.0M in H1 FY2025.
• · Long-term debt (net of current portion) increased to $115.8M as of April 30, 2026 from $92.8M as of October 31, 2025.
• · The company borrowed $100M under long-term debt obligations and made $91M in principal payments on long-term debt during H1 FY2026.
• · Inventory rose 44.7% to $116.6M, driven by a doubling of crop growing costs to $59.5M.
• · Basic and diluted loss per share was $(0.10) for Q2 FY2026, compared to earnings per share of $0.04 in Q2 FY2025.
• · The company repurchased and retired 173,900 shares of common stock for $2.2M during the three months ended April 30, 2026.

08-06-2026

Elastic N.V. reported a strong turnaround for the fiscal year ended April 30, 2026, with total revenue increasing 17% to $1,739.3M and net income of $367.8M compared to a net loss of $108.1M in the prior year. The company achieved a 20% improvement in gross profit, reaching $1,323.1M, and reduced its operating loss from -$54.9M to -$33.5M. However, the net income was significantly boosted by a $370.1M income tax benefit, and operating margin remained negative at -2%.

• · Operating loss narrowed from -$54.9 million in FY 2025 to -$33.5 million in FY 2026, a 39% improvement, but the company remained unprofitable on an operating basis.
• · Stock-based compensation expense and related employer taxes increased 14% year-over-year to $308.2 million, representing 18% of revenue in both FY 2026 and FY 2025.
• · Gross profit margin improved to 76% in FY 2026 from 74% in FY 2025, driven by faster growth in subscription revenue versus cost of subscription revenue.
• · Subscription revenue comprised 94% of total revenue in FY 2026, up from 93% in FY 2025, while services revenue share declined from 7% to 6%.
• · Amortization of acquired intangibles decreased to $8.8 million in FY 2026 from $9.2 million in FY 2025.
• · Income tax benefit of $370.1 million in FY 2026 was the primary driver of net income, compared to a provision of $76.5 million in FY 2025.

08-06-2026

Mama's Creations, Inc. reported strong Q1 FY26 results for the three months ended April 30, 2026, with net sales surging 49.7% YoY to $52.8M and net income rising 66.3% to $2.1M. The company also improved gross margin to 23.5% from 26.0% in the prior year period, while operating cash flow decreased 16.6% to $5.0M. Total assets grew to $87.5M from $85.7M at year-end, and stockholders' equity increased to $55.4M.

• · Gross margin declined to 23.5% in Q1 FY26 from 26.0% in Q1 FY25, despite higher absolute gross profit.
• · Operating cash flow decreased 16.6% YoY to $5.0M from $6.0M, primarily due to changes in working capital.
• · Selling, general and administrative expenses increased 28.5% YoY to $9.7M, but as a percentage of net sales decreased to 18.3% from 21.4%.
• · Interest expense rose to $109K from $88K, while interest income increased to $90K from $30K.
• · The company had no income tax cash payments in Q1 FY26 versus $5K in Q1 FY25.
• · Capital expenditures were $177K in Q1 FY26, down from $539K in Q1 FY25.
• · Total debt (term loan, net) decreased to $5.1M from $5.4M at year-end.
• · Stock-based compensation nearly doubled to $580K from $305K YoY.
• · Diluted EPS was $0.05 for both periods, with diluted shares outstanding increasing to 43.3M from 39.4M.
• · Trade incentives and promotions decreased to $1.85M from $2.25M YoY.

08-06-2026

Optical Cable Corp (OCC) reported a strong turnaround for the three and six months ended April 30, 2026, with net income of $1.05M (Q2) and $0.66M (H1) compared to net losses of $0.70M and $1.81M in the prior-year periods. Revenue grew 26.6% in Q2 to $22.21M and 16.1% in H1 to $38.64M, driven by increases in both domestic and international sales. However, the company's cash position declined sharply to $145,600 from $237,508 at October 31, 2025, and retained earnings turned negative at ($525,362), reflecting the accumulated deficit from prior losses.

• · Q2 2026 gross profit was $7.59M, up from $5.33M in Q2 2025.
• · Selling, general and administrative expenses increased to $6.27M in Q2 2026 from $5.74M in Q2 2025.
• · Interest expense net was $234,445 in Q2 2026, slightly down from $248,826 in Q2 2025.
• · Cash used in operating activities was $1.36M in H1 2026 vs. cash provided of $2.82M in H1 2025.
• · Total assets increased to $42.41M at April 30, 2026 from $40.06M at October 31, 2025.
• · Total liabilities increased to $20.17M from $18.49M over the same period.
• · Shareholders' equity decreased to $15.22M from $16.51M.
• · The company had $7.33M drawn on its revolver at April 30, 2026, up from $5.62M at October 31, 2025.
• · Long-term debt (excluding current installments) was $2.59M at April 30, 2026, compared to $0 at October 31, 2025.

08-06-2026

VitaSpring Biomedical Co. Ltd. filed its 10-K annual report for the fiscal year ended January 31, 2025, reporting no revenue for the second consecutive year. The company reduced its net loss by 30.7% to $774,922 from $1,118,562 in the prior year, primarily due to lower operating expenses. However, the company's financial position weakened significantly, with total assets falling 89.5% to $14,378, current assets declining to just $272, and working capital deficit widening to ($4,029,306) from ($3,463,904).

• · The company has no revenue for the second consecutive fiscal year.
• · Operating expenses decreased 39.2% to $679,914 from $1,118,562, primarily driving the net loss reduction.
• · Cash balance improved to $272 from $13, but remains negligible.
• · Total assets collapsed 89.5% to $14,378, mainly due to the elimination of deposits ($23,614 to $0) and operating lease right-of-use asset ($89,652 to $0).
• · Current liabilities increased 15.5% to $4,029,578, driven by higher accounts payable and advances from related party.
• · Working capital deficiency worsened 16.3% to ($4,029,306).
• · Stockholders' deficit deepened 19.9% to ($4,015,200) as accumulated deficit grew to ($5,281,503).
• · Cash used in operations improved 58.0% to ($14,675) from ($34,920).
• · Financing activities provided $14,934, up 183% from $5,277, indicating continued reliance on external funding.
• · The company's business model focuses on R&D, contract manufacturing, and future commercialization of stem-cell and exosome products, but remains pre-revenue.
• · The independent registered public accounting firm's PCAOB ID is 6723.

08-06-2026

Columbus McKinnon reported a net loss attributable to the Company of $229.5M for FY2026 vs a net loss of $5.1M in FY2025 and net income of $46.6M in FY2024. Revenue grew 23.9% to $1,193.5M, largely driven by the acquisition of Kito Crosby Limited for $2.8B, which added $1.1B in channel partner customer relationships. However, the company recorded a $200M goodwill impairment on the Precision Conveyance reporting unit and incurred $24.2M in debt refinancing costs, contributing to the operating loss of $119.3M compared to operating income of $54.6M in the prior year.

• · R&D expenses declined to $21.4M in FY2026 from $23.9M in FY2025 and $26.2M in FY2024, a 10% and 18% decrease respectively.
• · Interest and debt expense increased 88.5% to $61.1M from $32.4M.
• · Cost of debt refinancing was $24.2M in FY2026.
• · Net gain on sales of businesses of $103.3M partially offset operating losses.
• · Total debt (current + non-current) increased to $2,393.0M from $471.0M, driven by Kito Crosby acquisition financing.
• · Cash flow from operations was negative $146.2M vs positive $45.6M in prior year.
• · Goodwill impairment of $200.0M on Precision Conveyance reporting unit was driven by lower projected revenue growth rates and EBITDA margins.
• · Dividends remained flat at $0.28 per common share for all three years presented.
• · The Company issued 800,000 preferred shares totaling $789.8M (net of expenses $781.0M).

08-06-2026

Birdie Win Corp (BRWC) filed its 10-Q for the quarter ended April 30, 2026, reporting revenue of $5,000 for the three months (flat YoY) and $15,000 for the nine months (down 40% from $25,000). Net loss improved to $4,814 for the quarter (from $6,855) but widened to $21,338 for the nine months (from $6,033). Cash increased to $6,032 from $2,171, but the company has negative stockholders' equity of $6,968.

• · Accounts receivable were zero as of April 30, 2026, down from $10,000 (gross) with full allowance as of July 31, 2025.
• · Prepayments decreased to $5,000 from $17,399, including $nil prepayment to related party (vs $14,000).
• · Amount owing to director increased to $15,500 from $0.
• · Accrued liabilities decreased to $2,500 from $5,200.
• · General and administrative expenses for the nine months ended April 30, 2026 were $36,338, up from $30,897 in the prior period.
• · Stock-based compensation for consulting services was $14,000 for the nine months ended April 30, 2026, down from $24,000.
• · Net cash provided by operating activities was $3,861 for the nine months ended April 30, 2026, compared to cash used of $77 in the prior period.
• · No shares were issued during the nine months ended April 30, 2026; in the prior period, 960,000 shares were issued for $24,000.
• · Weighted average shares outstanding for basic and diluted EPS were 6,720,000 for both three and nine months ended April 30, 2026, up from 6,417,978 and 5,974,505 respectively in the prior year.

08-06-2026

Cuentas Inc. reported a net loss of $497,000 for Q1 2026, widening from a $399,000 loss in Q1 2025, driven by higher operating expenses and new equity losses. Total assets declined to $884,000 from $962,000 at year-end 2025, while total liabilities decreased to $4.31 million from $4.91 million. The company raised $600,000 through share issuance and converted $373,000 of notes into equity, but its accumulated deficit grew to $60.3 million.

• · Cash used in operating activities increased to $190,000 in Q1 2026 from $15,000 in Q1 2025.
• · The company had a stockholders' deficit of $3.43 million as of March 31, 2026, improving from a deficit of $3.95 million at year-end 2025.
• · Notes and loan payable decreased to $1.47 million from $1.82 million at December 31, 2025.
• · Loss per share improved to $(0.09) in Q1 2026 from $(0.15) in Q1 2025 due to a higher share count.
• · Related party receivables from Arik Maimon and Michael De Prado totaled $472,000 as of March 31, 2026.
• · Notes payable to related parties (Arik Maimon and Michael De Prado) remained unchanged at $969,000.

08-06-2026

AstroNova reported a net income of $653K for Q1 FY27, a significant turnaround from a net loss of $376K in Q1 FY26. Revenue grew 4.4% to $39.36M, driven by a 22% increase in hardware sales. However, supplies revenue declined 5.8% YoY, and the company experienced a foreign currency translation loss of $366K, partially offsetting the improved profitability.

• · Revenue by geography: US $24.08M (61.2% of total), Europe $10.21M (25.9%), Canada $1.56M, Asia $1.69M, Central and South America $1.31M, Other $0.53M.
• · Asia revenue declined 14.0% YoY from $1.96M to $1.69M.
• · Central and South America revenue declined 2.7% YoY from $1.34M to $1.31M.
• · Total debt (revolving credit facility + long-term debt) stood at $35.90M at April 30, 2026, down from $37.60M at January 31, 2026.
• · Interest expense decreased 24.7% YoY from $897K to $675K.
• · Foreign currency translation loss of $366K in Q1 FY27 vs. a gain of $975K in Q1 FY26.
• · Share-based compensation was $389K in Q1 FY27 vs. $306K in Q1 FY26.

08-06-2026

Oil-Dri Corp of America reported net sales of $364.6M for the nine months ended April 30, 2026, up 1.2% from $360.4M in the prior year period. Net income increased to $42.6M from $40.9M, a 3.9% rise. However, gross profit declined 6.2% to $101.5M from $108.3M, and operating income fell 5.4% to $49.7M from $52.6M. For the third quarter alone, net sales grew 9.4% to $126.3M, net income rose 24.7% to $14.5M, but gross margin contracted.

• · Cash provided by operating activities for nine months was $53.2M, down from $55.0M in prior year.
• · Capital expenditures were $20.9M for nine months, compared to $24.5M in prior year.
• · Dividends declared per common share increased to $0.590 for nine months from $0.465.
• · Treasury stock purchases totaled $12.5M for nine months, up from $2.2M.
• · Total liabilities decreased to $123.6M at April 30, 2026 from $132.6M at July 31, 2025.
• · Accumulated other comprehensive income was $0.976M at April 30, 2026, compared to $0.969M at July 31, 2025.

08-06-2026

Vail Resorts reported a decline in total net revenue for both the three and nine months ended April 30, 2026, compared to the same periods in 2025. Net income attributable to Vail Resorts decreased 19.3% to $314.4M for the quarter and 26.7% to $337.7M for the nine-month period. However, the company reduced total liabilities by $254.1M from July 2025 and improved stockholders' equity by $162.2M over the same period.

• · Lift revenue declined 5.3% to $729.4M for the quarter and 3.5% to $1.405B for the nine-month period.
• · Ski School revenue fell 11.5% to $141.8M for the quarter and 9.9% to $270.3M for the nine-month period.
• · Dining revenue decreased 10.7% to $99.1M for the quarter and 8.5% to $203.6M for the nine-month period.
• · Retail/Rental revenue declined 8.3% to $104.2M for the quarter and 6.2% to $261.0M for the nine-month period.
• · Owned hotel rooms revenue dropped 14.9% to $12.9M for the quarter and 4.5% to $54.0M for the nine-month period.
• · Managed condominium rooms revenue fell 13.1% to $28.3M for the quarter and 10.2% to $64.1M for the nine-month period.
• · Transportation revenue decreased 22.9% to $5.2M for the quarter and 17.2% to $11.4M for the nine-month period.
• · Interest expense increased 22.5% to $51.3M for the quarter and 19.4% to $152.1M for the nine-month period.
• · Provision for income taxes decreased 18.8% to $105.6M for the quarter and 25.6% to $117.3M for the nine-month period.
• · Cash and cash equivalents decreased 20.5% from $467.0M (April 30, 2025) to $371.4M (April 30, 2026).
• · Long-term debt due within one year decreased from $591.5M (April 30, 2025) to $73.5M (April 30, 2026), while long-term debt (net) increased from $2.119B to $2.950B over the same period.
• · Dividends declared per share remained flat at $2.22 per quarter and $6.66 for the nine-month period.
• · Weighted-average basic shares outstanding decreased 4.3% from 37,241 to 35,633 for the quarter.

08-06-2026

G-III Apparel Group reported a strong Q1 FY26 (ended April 30, 2026) with net income surging to $66.5M from $7.8M in the prior-year quarter, driven by a dramatic improvement in gross margin to 64.9% from 42.3%. However, net sales declined 8.2% to $536.0M from $583.6M, and operating cash flow turned negative at -$2.0M versus $93.8M a year ago, reflecting a significant increase in prepaid expenses and lower payables.

• · Gross margin improved dramatically to 64.9% in Q1 FY26 from 42.3% in Q1 FY25, driven by a 44.2% reduction in cost of goods sold ($188.2M vs $337.1M).
• · SG&A expenses increased 10.3% to $255.3M from $231.5M, partially offsetting gross profit gains.
• · Operating profit surged to $85.2M from $8.5M, a 905% increase.
• · The company paid $4.2M in dividends ($0.10 per share) in Q1 FY26, compared to none in the prior-year period.
• · No share repurchases occurred in Q1 FY26, versus $19.7M in Q1 FY25.
• · Foreign currency translation resulted in a loss of $8.3M in Q1 FY26, compared to a gain of $16.1M in Q1 FY25.
• · Accounts receivable decreased to $432.9M from $481.1M (YoY), while inventories declined to $417.9M from $456.5M.
• · Prepaid expenses and other current assets surged to $191.5M from $50.7M (YoY), a 278% increase, contributing to the negative operating cash flow.
• · Total debt (notes payable) was $15.4M as of April 30, 2026, up from $11.7M at January 31, 2026, but down from $18.7M a year ago.
• · Allowance for doubtful accounts increased to $18.7M from $10.2M (YoY), indicating higher credit risk in wholesale receivables.